Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TRANSITION THERAPEUTICS INC. T.TTH

"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."


TSX:TTH - Post by User

Comment by Data101on Oct 24, 2007 11:19am
229 Views
Post# 13679133

RE: Novo?

RE: Novo?Well, my feeling is that they weren't properly advised when they proceeded with the stock split and Nasdaq listing. They were in no hurry to do that and should have waited to pair it with a strong positive NR.

Now, invesors relations is not doing their job IMO and leaving investors in the dark as to guidance regarding this whole situation. They could at least issue a statement telling investors that they are not aware of any material fact supporting the stock slide.

Anyway, I have been in this stock for more than 3 years now and I' m willing to wait one more week. If there are no NR as to the NNN deal or ELan milestone payment, I guess this will be a write-oof for me

Data

Bullboard Posts